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The present study. In this issue of the Journal . White ei
al. (1) present their angiographic and histopathologic obser-
vations after placement of the Medtronic Wiktor stem, a
radiopaque balloon-expandable tantalum scent, in a small
number of cholesterol-loaded atherogenic swine with normal
peripheral and coronary arteries,'l'hey serially harvested the
stented arteries after angiographv at 1, 4 .6 and 32 weeks and
attempted to quantitate the pateney rate and the extent of
intimal proliferation. Thr authors (I) limited their discussion
to prior studies of stents performed in rabbit models
(2),
missing the opportunity to compare their findings with the
observations by other investigators using the Wiktor stent in
porcine coronary arteries (3,4) or other metallic stents pre-
viously tested in canine coronary arteries (5,6). The authors
(I) concluded that on the basis of serial histologic analysis
the Wiktor scent shows " . . . no evidence of causing an
excessive proliferative healing response leading to stenosis
of the prosthesis in this animal model of atherosclerosis ."
We have tested a variety of stents, including the Wiktor
stent, in a normolipemic and hypcrlipemic swine coronary
artery model of restenosis, In the swine model, cholesterol
loading does not alter the progression of smooth muscle
proliferation in stented or balloon-injured coronary arteries
(7). We found the Wiktor stem to be flexible, easy to deploy
and radiopaque, but most important, like other metallic
intravascular stents (5,6,8), the Wiktor stenl promotes sig-
nificant intimal smooth muscle proliferation . In an early
clinical report (9) involving lot patients who received a
single Wiktor stunt, the rate of restenosis was 28% to 48%
and this appears to confirm that the Wiktor stent is associ-
ated with a proliferative process similar to that of other
stents in clinical trials . The study by White et al
. (I)
illustrates many potential pitfalls that must be taken into
account when evaluating metallic intravascular stents in
experimental animal models . The choice of the animal model
is an important first step in the testing of any endoprosthetic
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device. We have employed the rabbit (2),
canine (5) and
porcine models for testing of the Gianturco-Rouhin stem in
our laboratory and found that each model has specific utility
to evaluating intravascular stems We believe that the swine
model is a good model for testing intravascular stents and
devices because porcine coronary arteries are similar to
human arteries with respect to size. laminar flow character-
istics (10),
platelet-coagulation system (11) and propensity to
develop intimal hyperplasia (3,4) similar to that of human
proliferative lesions
.
Comments regarding the htstopetholugic analysis of the
vessels. First . the mtthors (1) chose to combine the analysis
of elastic peripheral arteries with that of muscular coronary
arteries which . from the information provided in their study .
appear to have greater associated intimal proliferation
.
Deeper or more extensive arterial wall injury usually results
in more intimal proliferation (12,13) . White et al. (1) at-
tempted to size the stunt 10% to 15% larger than the artery,
which is similar to the clinical sizing of stents (13). However,
measurement of the stunt after implantation demonstrates
that the stent closely matched the arterial size and in several
cases actually was undersized . The use of an injury grading
system proposed by Schwartz et al. (12) or Katas et al . (4)
helps ensure that vessels sustained equal injury before
intimal proliferation is compared .
The authors (I) did not provide the percent of vessels in
which the internal elastic lamina or media was fractured by
the stunt placement. However, the photomicrographs of the
stented arteries presented in this study (I) appear to have an
intact internal elastic lamina . In our swine model, stents that
were undersized and did not fracture the internal elastic
lamina had only minimal proliferation when compared with
stents that were oversized by 15% to 20% and fractured the
internal elastics. The extent of intimal proliferation reported
by White et al . (1) was not insignificant when measured by
the maximal intimal thickness . In some vessels the maximal
intimal thickness was >450 pm, very similar to the intimal
proliferation reported by Karas et al . (4) from mar labura-
tory- The lack of a comparison control group subjected to
balloon injury alone brings into question the implication that
the absence
of obstruction at the stem site was due to the
presence of this scent.
htllammatory
,
reaction to the steal. White et al . (1) found
no significant inflammatory reaction to the tantalum stents .
In contrast, we observed (4) a significant inflammatory
reaction in 66% of the vessels stented with the Wiktor stunt
and other stents 4 weeks after implantation . Thu inflamma-
tory reaction was heralded by segmented cells within I week
and eosinophil infiltration and granuloma formation around
the scent wires were seen at 4 weeks in our swine model of
intimal proliferation (4). We have also observed that the
Wiktor scent creates an irregular surface formed by the
redundant coils that
differs from the smooth contours seen
with slotted tube stents . This observation can be made
because of the capability of sectioning and processing the
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vessel with the metallic stent in place rather than removing
the stem before histologic processing .
Smooth muscle proliferation . The early findings of mild
thrombus formation, inlimal proliferation and reendothelial-
iration with the Wiktnr %tent are very similar to early
observations made by Roubin et al . (5) after Gianlurco-
Roubin scent implantation and by Schatz et al . (6) using the
Pdlmaz
Schatz stent in canine coronary arteries . The de-
crease in the mass of smooth muscle cells and extracellular
matrix and the replacement by fibrotic tissue resembling a
scar at 32 weeks was similar to our 12-month observations of
the Gianturco-Roubin stent in canine coronary arteries (4).
Three months after implantation of the Wiktor stem in our
swine model (14), the smooth muscle proliferation continued
to progress, whereas in animals that received balloon injury
alone, no further progression of intimal hyperplasia was
demonstrated after 2 weeks . We conclude from these data
that the presence of the stent compressing the media may
have created a continuous stimulus for smooth muscle
hypertrophy and proliferation, The article by White et al
. (I)
suggests that the proliferative process is finite and ceases at
some time after6 weeks. This apparent discrepancy between
our results and data presented by White et al . (I) may be due
to differences in the stem/artery size ratio ; however, their
study did not examine vessels at 3 and 6months to determine
at which point the proliferative process ceases .
Stems and proliferative swine models of restenosis . The
observation that stents induce intimal proliferation provided
the basis for the development of proliferative swine models
of restenosis by Kams et al. (4) in our laboratory and by
Schwartz et al
. (3) at the Mayo Clinic. Both of these models
involve the placement of tantalum coil steals in normoli-
pemic porcine coronary arteries . The resultant intimal pro-
liferation provides an easy and affordable model in which to
test potentially beneficial agents . It is unclear why stents
induce the development of
smooth muscle proliferation, but
the cause may be related to compression or damage of the
media, the internal elastic lamina or a thrombotic or inflam-
matory reaction of the artery to the metallic stem as a foreign
body.
These proliferative models have attracted much attention
because the smooth muscle proliferation induced by %tenting
is histologically similar to the human proliferative process
(3,4),
The most striking similarity between the proliferative
swine models and humans is that agents shown to inhibit
inlimal proliferation in rats (15) and rabbits (16) have not
been found to be beneficial in pigs (14) or humans (17) .
Potentially beneficial therapeutic agents may need to be
tested first in the swine model ofrestenosis before expensive
human trials are launched .
Steuts and restenosis. If stents promote smooth muscle
proliferation, why would we expect them to reduce the
incidence of restenosis? If stents improve the restenosis
rate, it is because those patients receiving a stent have an
improved initial angiographic result and, despite continued
myointimal growth, continue to have an improved residual
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lumen at the 6-month follow-up study (18,19) . If the myo .
proliferative process is indeed finite as suggested by White et
al . (1) and confirmed in a small clinicnl rant (20) that
examined the restenosis rate of starts after 6 months, then
the initial angiographic improvement may be all that is
needed to reduce the reslenusiss rate. On the other hand, if
smooth muscle proliferation must be reduced further, phar-
maeologic intervention may also be an important adjunct.
Ultimately, it may nut be subtle design features that make
a difference in long-term stem results but the development of
an effective antithrnmhotic and antiproliferntivc adjunctive
therapy to accompany slanting . If that is the case, stents
with the user-friendly features described by White et al,
(I)
may be very popular .
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